These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 25776490)

  • 1. Molecularly targeted gemcitabine-loaded nanoparticulate system towards the treatment of EGFR overexpressing lung cancer.
    Wang XB; Zhou HY
    Biomed Pharmacother; 2015 Mar; 70():123-8. PubMed ID: 25776490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AS1411 Aptamer-Decorated Biodegradable Polyethylene Glycol-Poly(lactic-co-glycolic acid) Nanopolymersomes for the Targeted Delivery of Gemcitabine to Non-Small Cell Lung Cancer In Vitro.
    Alibolandi M; Ramezani M; Abnous K; Hadizadeh F
    J Pharm Sci; 2016 May; 105(5):1741-1750. PubMed ID: 27039356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.
    Youngren-Ortiz SR; Hill DB; Hoffmann PR; Morris KR; Barrett EG; Forest MG; Chougule MB
    J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):299-321. PubMed ID: 28277892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR-Targeted Cationic Polymeric Mixed Micelles for Codelivery of Gemcitabine and miR-205 for Treating Advanced Pancreatic Cancer.
    Mondal G; Almawash S; Chaudhary AK; Mahato RI
    Mol Pharm; 2017 Sep; 14(9):3121-3133. PubMed ID: 28719220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GEM-loaded magnetic albumin nanospheres modified with cetuximab for simultaneous targeting, magnetic resonance imaging, and double-targeted thermochemotherapy of pancreatic cancer cells.
    Wang L; An Y; Yuan C; Zhang H; Liang C; Ding F; Gao Q; Zhang D
    Int J Nanomedicine; 2015; 10():2507-19. PubMed ID: 25848268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine.
    Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN
    Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer.
    Kumari L; Ehsan I; Mondal A; Al Hoque A; Mukherjee B; Choudhury P; Sengupta A; Sen R; Ghosh P
    J Drug Target; 2023 Jun; 31(5):521-536. PubMed ID: 37010248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Therapeutic Effects of
    Wu P; Zhu H; Zhuang Y; Sun X; Gu N
    Int J Nanomedicine; 2020; 15():2777-2787. PubMed ID: 32368054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine-Phospholipid Complex Loaded Lipid Nanoparticles for Improving Drug Loading, Stability, and Efficacy against Pancreatic Cancer.
    Dora CP; Kushwah V; Yadav V; Kuche K; Jain S
    Mol Pharm; 2024 Jun; 21(6):2699-2712. PubMed ID: 38747900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy.
    Esim O; Ozkan CK; Sarper M; Savaser A; Ozkan Y
    Curr Drug Deliv; 2020; 17(7):622-628. PubMed ID: 32394837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice.
    Kim IY; Kang YS; Lee DS; Park HJ; Choi EK; Oh YK; Son HJ; Kim JS
    J Control Release; 2009 Nov; 140(1):55-60. PubMed ID: 19616596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine-based polymer-drug conjugate for enhanced anticancer effect in colon cancer.
    Liang TJ; Zhou ZM; Cao YQ; Ma MZ; Wang XJ; Jing K
    Int J Pharm; 2016 Nov; 513(1-2):564-571. PubMed ID: 27613255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine-loaded RGD modified liposome for ovarian cancer: preparation, characterization and pharmacodynamic studies.
    Tang Z; Feng W; Yang Y; Wang Q
    Drug Des Devel Ther; 2019; 13():3281-3290. PubMed ID: 31571830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual targeting pH responsive chitosan nanoparticles for enhanced active cellular internalization of gemcitabine in non-small cell lung cancer.
    Kumar K; Rawat SG; Manjit ; Mishra M; Priya ; Kumar A; Chawla R
    Int J Biol Macromol; 2023 Sep; 249():126057. PubMed ID: 37524283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinational dual drug delivery system to enhance the care and treatment of gastric cancer patients.
    Xiao Y; Gao Y; Li F; Deng Z
    Drug Deliv; 2020 Dec; 27(1):1491-1500. PubMed ID: 33100060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo.
    Yalcin TE; Ilbasmis-Tamer S; Takka S
    Int J Pharm; 2020 Apr; 580():119246. PubMed ID: 32205141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer.
    Hatami E; Nagesh PKB; Jaggi M; Chauhan SC; Yallapu MM
    Eur J Pharmacol; 2020 Dec; 888():173486. PubMed ID: 32805254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity.
    Sandoval MA; Sloat BR; Lansakara-P DS; Kumar A; Rodriguez BL; Kiguchi K; Digiovanni J; Cui Z
    J Control Release; 2012 Jan; 157(2):287-96. PubMed ID: 21871505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR-targeted hybrid lipid nanoparticles for chemo-photothermal therapy against colorectal cancer cells.
    Fang F; Zhang X; Tang J; Wang Y; Xu J; Sun Y
    Chem Phys Lipids; 2023 Mar; 251():105280. PubMed ID: 36634728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.